Biostimulants Market

How big is Biostimulants Market in 2026?

The biostimulants market is estimated at USD 4.1 billion in 2025 and is projected to reach USD 4.5 billion in 2026. Over the decade, the biostimulants market is likely to expand at a CAGR of 10.5% and reach USD 12.3 billion by 2036.

Key trends in the biostimulants market point to growers buying stress protection with the same urgency as pest control, as heat and drought cut yields in more seasons. USD 4.1 billion is the 2025 estimate for the biostimulants market, growth to USD 4.5 billion is expected in 2026, and a 10.5% CAGR between 2026 and 2036 is projected to take the total to USD 12.3 billion by 2036. Syngenta Group said biologicals sales continued to perform strongly across all regions in the first half of 2026.[1] Large crop protection groups now sell biostimulants through the dealers and agronomists who sell fungicides, so the products reach far more farms.

A heat map of buyers puts fruit and vegetable growers in the hottest zone. Fruits and vegetables are estimated at 36.2% of 2026 crop type sales, and berry, vine, citrus and greenhouse growers spray several times a season to protect produce prices. Row crops form the largest block, an expected 41%, but each hectare gets one low-cost pass, and cereal and oilseed growers skip the product in weak seasons. FMC cited strained grower margins in North America and reported lower Plant Health sales in the second quarter of 2026.[2] In FMI's assessment, suppliers will earn the steadiest orders from specialty growers and reach row crops through seed-applied formats.

Key Market Trends & Insights

• Extract-based products are expected to lead active ingredient sales with 42% share in 2026, ahead of acid-based humic and fulvic products at an estimated 33.5%. India added seaweed, protein hydrolysate and humic entries to the Fertiliser Control Order through a 2026 amendment, AgroSpectrum reported.[3]
• Cereal, oilseed and pulse acreage keeps row crops first on crop type, at a projected 41% of 2026 sales, with fruits and vegetables close behind near 36.2%.
• Sales of foliar biostimulants are projected to hold 49% of 2026 application sales, against about 34.7% for soil and drip products and 16.3% for seed coatings. An ASM seed treatment from Acadian Plant Health showed up to 16% higher maize yield under drought stress in company trials reported in May 2025.[4]

Regional Highlights

• India is first among the countries covered at an 11.7% CAGR, as fully approved products replace thousands of provisional registrations.
• Two more countries beat the 10.5% global CAGR, China leading that pair on 10.9%, ahead of Brazil's 10.6%. Japan follows on 9.9%, a little above South Korea on 9.6%. The United States, on 9.4%, comes just above Germany, which has the lowest rate in the table at 9.2%.
• Brazil had more than 200 registered bioinput companies, a rise of over 50% between 2022 and 2025, Revista Cultivar reported on 18 August 2026.[5]

Market Size & Forecast

Table 1: Market Size and Forecast for the Biostimulants Market (USD billion and percentage), 2025 to 2036

Metric	Value
2025 Market Size	USD 4.1 billion
Estimated Market Size in 2026	USD 4.5 billion
Projected Market Size by 2036	USD 12.3 billion
CAGR, 2026 to 2036	10.5%
Added Revenue, 2026 to 2036	USD 7.8 billion
Market Expansion Multiple	2.7x

Biostimulant orders follow planting calendars, with distributors stocking before the Brazilian soybean season from September and again before Northern Hemisphere spring. Syngenta Group reported 7% crop protection sales growth in Brazil in the first half of 2026, despite continued pricing pressure, and 8% growth in Europe.[1] Bioinput companies in Brazil generated more than R$7 billion in the 2024/2025 harvest, according to industry body Anpii Bio.[5] Growers who switch part of a mineral programme to compost and manure products are also buying biostimulants for the same fields, and the organic fertilizer market is predicted to rise at a 6.2% CAGR. Added sales of USD 7.8 billion are expected for the biostimulants market between 2026 and 2036 on the FMI outlook, taking 2036 sales to about 2.7 times the size expected in 2026. Farm income is the main risk, as growers cut optional inputs first when crop prices fall.

Registration Rules in India, Brazil, the United States and the EU

Rules are separating approved products from untested ones. India cancelled all 9,352 provisional biostimulant registrations from 17 June 2025, leaving 146 fully approved products listed under Schedule VI of the Fertiliser Control Order, Global Agriculture reported.[6] The Fourth Amendment Order, 2026 then added entries for seaweed extracts, protein hydrolysates, humic and fulvic acids, botanical products and mixed blends.[3] Companies with field data and dossiers will gain shelf space as unregistered blends leave Indian dealer stores.

The United States and the EU are writing clearer definitions. H.R. 3783, the Plant Biostimulant Act of 2025, was introduced in the House on 5 June 2025 to add a plant biostimulant definition to FIFRA and to direct EPA to revise the rules within 120 days of enactment.[7] In Europe, the Council confirmed the Chemicals Omnibus (VI) agreement on 26 June 2026, creating a criteria-based pathway for new micro-organisms in microbial plant biostimulants, EBIC said.[8] Brazil is finalising the decree for Law No. 15.070/2024 on bioinputs.[5] Each rule shortens the path from trial plot to labelled product.

Table 2: Regulation and Company Indicators for the Biostimulants Market (registrations, rules and sales), 2025 to 2026

Indicator	Data Point	Relevance	Source
India provisional registrations cancelled, June 2025	9,352 cancelled; 146 fully approved	Fewer but registered products	[6]
India Fertiliser Control Order amendment, 2026	Seaweed, protein hydrolysate, humic and blend entries added	Wider approved product range	[3]
Brazil bioinput companies, 2022 to 2025	More than 200; up over 50%	Growing supplier base	[5]
US Plant Biostimulant Act, June 2025	H.R. 3783 introduced	Proposed federal definition	[7]
EU Chemicals Omnibus (VI), June 2026	Criteria-based pathway for new micro-organisms	Faster microbial approvals	[8]
Syngenta Group crop protection sales, H1 2026	USD 6.6 billion; up 4%	Biologicals strong in all regions	[1]
FMC revenue, Q2 2026	USD 867 million; down 17%	Lower Plant Health sales	[2]

Analyst Perspective

“Specialty crop growers will carry the biostimulants market over the next ten years, as each spray on berries, vines or greenhouse vegetables protects a high-value harvest. I expect registration to sort the field, and companies that hold full approvals in India, CE-marked products in Europe and field data from Brazil will gain the dealer shelf first. Row crops become the larger prize once seed-applied doses cost less than one fungicide pass, and I would invest early in that format.”

- Nikhil Kaitwade, Principal Consultant, Future Market Insights.

How is the biostimulants market segmented?

The market is segmented into active ingredient, crop type, application, and region. Extract-based products are expected to lead active ingredient with 42% share in 2026, and foliar application is projected to lead with 49%.

By active ingredient: extract-based, acid-based, and others.

By crop type: row crops, fruits and vegetables, turfs and ornamentals, and other crop types.

By application: foliar, soil/drip, and seed/coating.

By region: farms, greenhouses and turf managers in North America, Latin America, Western Europe, Eastern Europe, East Asia, South Asia and Pacific, and Middle East and Africa.

Why do extract-based products lead biostimulants sales by active ingredient?

Extract-based products are expected to lead active ingredient sales with 42% share in 2026, ahead of acid-based products at an estimated 33.5% and other ingredients at about 24.5%.

Table 3: Active Ingredient Share for the Biostimulants Market (percentage share), 2026

Active Ingredient	Estimated Share (2026)
Extract-based	42%
Acid-based	33.5%
Others	24.5%
Total	100.0%

Table 4: Active Ingredient Leadership and Market Growth for the Biostimulants Market (segment and CAGR percentage), 2026 to 2036

Metric	Value
Global CAGR (2026 to 2036)	10.5%
Leading Segment	Extract-based

Field trials on stress tolerance favour extracts, so extract-based products are expected to lead in 2026 with a 42% share. Seaweed extracts from Ascophyllum nodosum and protein hydrolysates carry the longest history of yield and quality trials, and growers mix them into fungicide and nutrition sprays without a separate pass. At an estimated 33.5%, acid-based humic and fulvic products improve soil structure and nutrient holding, but results show up over seasons, which makes them harder to sell on a one-crop budget. Other ingredients, about 24.5%, include microbial amendments, peptides and trace minerals, and many still wait for clear approval routes. Amino acid blends draw on the same hydrolysis plants that serve feed and food, and a 9.7% CAGR forecast for the amino acids market keeps raw material supply growing for protein hydrolysate makers. Seaweed harvesting is a slower story, and the seaweed extracts market is expected to rise at a 4% CAGR across all uses. Growers will keep extracts as the first product tried, then add humic acids on poor soils.

• Seaweed extracts, protein hydrolysates and amino acid blends make up most extract-based volume.
• India's 2026 amendment listed seaweed extracts from Ascophyllum nodosum, Ecklonia maxima and Kappaphycus alvarezii, AgroSpectrum reported on 30 March 2026.[3]

Why do row crops lead biostimulants sales by crop type?

Row crops are expected to lead crop type sales with 41% share in 2026, ahead of fruits and vegetables at an estimated 36.2%, other crop types at 13.2% and turfs and ornamentals at 9.6%.

Table 5: Crop Type Share for the Biostimulants Market (percentage share), 2026

Crop Type	Estimated Share (2026)
Row Crops	41%
Fruits and Vegetables	36.2%
Other Crop Types	13.2%
Turfs and Ornamentals	9.6%
Total	100.0%

Hectares decide the row crop lead, a projected 41% share in 2026, as soybean, maize, wheat and rice fields cover far more ground than any other crop group. Per hectare, fruits and vegetables buy more product, an estimated 36.2% of sales, since berry, grape, citrus and greenhouse growers spray several times and sell on visible quality. Other crop types, near 13.2%, cover plantations, herbs, spices and flowers, with high use on estates and low use among smallholders. Turfs and ornamentals, about 9.6%, come from golf courses, sports grounds and nurseries buying on turf colour and recovery after stress. Brazil had more than 200 registered bioinput companies by 2025, many selling to soybean and maize growers.[5] Row crops will keep the volume lead, and fruit and vegetable growers will keep paying the highest price per hectare.

• Soybean, maize, wheat, rice and pulses form the row crop base.
• Syngenta Group said Brazil delivered 7% crop protection sales growth in the first half of 2026, with biologicals strong across all regions.[1]

Why does foliar application lead biostimulants sales by application?

Foliar application is projected to lead with 49% share in 2026, against an estimated 34.7% for soil/drip and 16.3% for seed/coating.

Table 6: Application Share for the Biostimulants Market (percentage share), 2026

Application	Estimated Share (2026)
Foliar	49%
Soil/Drip	34.7%
Seed/Coating	16.3%
Total	100.0%

Tank mixing keeps foliar application ahead, at a projected 49% share in 2026, as growers add a biostimulant to a spray already planned for a fungicide or micronutrient and pay nothing extra for the pass. Greenhouses and drip-irrigated orchards favour soil and drip products, an estimated 34.7%, as fertigation feeds humic acids and microbes straight to the roots. Microbial soil products overlap with inoculants, and the biofertilizers market is likely to increase at an 8.5% CAGR, which puts more microbial products into the same drip lines. Potash still anchors most soil nutrition programmes, and with the potassium chloride market forecast to grow at a 3.1% CAGR, biostimulants will grow faster as an add-on than the base fertiliser. Seed and coating products, about 16.3%, are the smallest group, as each hectare needs only a few grams. Seed treatment will be the fastest route into row crop farms.

• Single-pass foliar with nutrition, multi-pass stress sprays and micro-dose specialty foliar make up the foliar segment.
• Acadian Plant Health launched the ASM seed treatment in May 2025 and reported a 28% to 35% increase in soybean root biomass.[4]

What are the drivers, restraints, and opportunities in the biostimulants market?

Heat, drought and quality premiums push growers toward stress protection. Weak farm margins and the cost of registration slow sales, and clearer national rules open room for approved microbial and extract products.

• Driver: More frequent heat and drought stress lead growers of high-value crops to treat biostimulants as insurance for yield and quality.
• Restraint: Row crop farmers drop optional inputs when margins tighten, and smaller suppliers struggle to pay for field trials and dossiers.
• Opportunity: Clear definitions and approval routes let companies with proven products sell into dealer networks that once avoided the category.

Stress Protection Becomes Part of the Spray Plan

Adoption of biostimulants rises fastest on farms that can lose the premium on a whole harvest to one bad week of heat. Syngenta Group tied 20% growth in China to demand for the latest technologies and biologicals in the first half of 2026.[1] Company trials of a seaweed-based seed treatment from Acadian Plant Health showed up to 16% higher maize yield under drought stress.[4] Large agrochemical groups will keep folding biostimulants into seasonal spray programmes, so growers buy them with products already on the order.

Farm Margins and Dossier Costs Slow Sales

Producers of biostimulants face price-sensitive row crop buyers and the cost of proving a product. FMC reported Q2 2026 revenue of USD 867 million, down 17%, citing growers who contend with strained margins in North America.[2] India cancelled 9,352 provisional registrations in June 2025, leaving 146 fully approved products.[6] FMI expects small formulators without trial data to sell out to larger groups. Large suppliers will absorb the dossier cost and gain the dealer listings that small firms lose.

Clearer Rules Open New Product Classes

Sales potential is opening in product classes that lacked a legal route until 2026. The Chemicals Omnibus (VI) agreement gives microbial biostimulants a criteria-based pathway for new strains in the EU.[8] India's 2026 amendment added botanical and sterol-based biochemical products to the approved list.[3] These rules are giving microbial and botanical blends a quicker road to the dealer shelf, as approval no longer waits for a strain-by-strain listing.

Which country CAGRs are profiled in the biostimulants market?

Table 7: Country CAGR Comparison for the Biostimulants Market (CAGR percentage), 2026 to 2036

Country	CAGR (2026 to 2036)
India	11.7%
China	10.9%
Brazil	10.6%
Japan	9.9%
South Korea	9.6%
United States	9.4%
Germany	9.2%

How do country-level CAGRs compare in the biostimulants market?

Indian regulators struck 9,352 provisional biostimulant registrations in June 2025 and kept 146 fully approved products.[6] FMI's model shows India at an 11.7% CAGR, the highest in the table, as dealers restock with registered products. China follows at 10.9% on protected vegetable and fruit acreage, and Brazil at 10.6% on soybean and sugarcane programmes. Japan and South Korea, on 9.9% and 9.6%, rely on greenhouse and rice growers with small farm areas. The United States is projected at 9.4%. Germany, at 9.2%, is short of the 10.5% rate for the biostimulants market as a whole, as EU rules on fertilising products have only begun to bring microbials into the CE system.

• Indian dealers are restocking with fully approved products after provisional permits ended.
• Protected vegetable and fruit farms keep foliar programmes growing in China.
• Soybean and sugarcane growers in Brazil buy bioinputs at scale.
• Greenhouse vegetables and rice shape use in Japan.
• South Korean greenhouse growers apply biostimulants through fertigation.
• Specialty crop growers in California and Florida lead use in the United States.
• German arable farms are slower to add biostimulants to cereal programmes.

Full report country CAGRs cover: A three-country group of India, China and Brazil runs above the 10.5% global rate, India highest at 11.7%. Japan comes next on 9.9%, with South Korea on 9.6% and the United States on 9.4%. Germany completes the profiled set at 9.2%, and the remaining standard countries are covered in regional figures.

Country-wise Analysis

India Biostimulants Market Outlook (2026 to 2036)

An 11.7% CAGR puts India at the top of the biostimulants table. The Fourth Amendment Order, 2026 added seaweed, protein hydrolysate, humic, botanical and mixed-blend entries with composition and crop guidance, AgroSpectrum reported on 30 March 2026.[3] Before that, the end of provisional permits in June 2025 cut the approved list to 146 products.[6] Registered suppliers are now filling the dealer gap left by thousands of withdrawn products.

Key takeaway: Full registration resets supply and drives India.

China Biostimulants Market Outlook (2026 to 2036)

Greenhouse vegetables, fruit orchards and tea gardens give China a 10.9% CAGR in the biostimulants table. Syngenta Group reported 20% growth in China for the first half of 2026, linked to continued demand for the latest technologies and biologicals.[1] Domestic seaweed and humic acid producers supply most volume, and global groups compete on branded stress-protection products.

Key takeaway: Protected horticulture and branded biologicals carry China.

Brazil Biostimulants Market Outlook (2026 to 2036)

Brazilian soybean, maize and sugarcane growers adopted bioinputs early, and sector sales exceeded R$7 billion in the 2024/2025 harvest, Anpii Bio told Revista Cultivar.[5] The decree for Law No. 15.070/2024 was expected in the weeks after 18 August 2026, setting rules for registration, labelling and on-farm production. FMI's model shows Brazil at 10.6%, a little ahead of the global CAGR.

Key takeaway: Bioinput law and soybean acreage support Brazil.

Japan Biostimulants Market Outlook (2026 to 2036)

Japanese greenhouse tomato, strawberry and cucumber growers buy foliar and drip products to protect quality on small, high-value plots. Rice farmers add root stimulants in transplant season. FMI projects Japan at a 9.9% CAGR, below the global rate, as farm numbers keep falling and older growers change input programmes slowly.

Key takeaway: Japan relies on greenhouse growers who pay for quality.

South Korea Biostimulants Market Outlook (2026 to 2036)

Demand for biostimulants in South Korea comes mainly from greenhouse vegetable and fruit growers who feed nutrients through fertigation. Seaweed and amino acid products go into the same drip lines as fertiliser. A 9.6% CAGR is forecast for South Korea, as the farmed area is small and much of the greenhouse base already uses the products.

Key takeaway: Fertigated greenhouses anchor South Korea.

United States Biostimulants Market Outlook (2026 to 2036)

The United States receives a 9.4% CAGR in the FMI outlook. H.R. 3783, introduced on 5 June 2025, proposes a federal definition of plant biostimulant under FIFRA and a USDA study on nutrient runoff and soil organic matter.[7] FMC said growers contended with strained margins, particularly in North America, in the second quarter of 2026.[2] Specialty crop growers in California and Florida will keep buying, and row crop farms will wait for clearer labels and better crop prices.

Key takeaway: A pending federal definition and tight farm margins shape the United States.

Germany Biostimulants Market Outlook (2026 to 2036)

Vegetable, potato and vineyard growers lead demand for biostimulants in Germany, and arable farms are slower to add a product to cereal programmes. The EU confirmed a criteria-based pathway for new microbial strains in June 2026, EBIC said.[8] Germany, at 9.2%, is short of the 10.5% rate for the biostimulants market as a whole, though microbial approvals will widen the product range sold through German cooperatives.

Key takeaway: Arable farms slow to adopt hold Germany to 9.2%.

Who are the notable companies in the biostimulants market?

BASF, Valagro (Syngenta Biologicals), UPL, Koppert, Acadian Plant Health, FMC, BioAtlantis, Hello Nature (Italpollina), Tradecorp (Rovensa) and Omnia Nutriology are the profiled companies.

Top companies operating in the biostimulants market include crop protection majors, seaweed specialists and biological input firms, and FMI lists ten. Biologicals sales at Syngenta Group, owner of Valagro, performed strongly across all regions in the first half of 2026.[1] Acadian Plant Health, a seaweed specialist, launched the ASM seed treatment for drought, heat and cold stress in May 2025.[4] FMC reported lower Plant Health sales in the second quarter of 2026.[2] BASF, UPL, Koppert, BioAtlantis, Hello Nature (Italpollina), Tradecorp (Rovensa) and Omnia Nutriology complete the group.

• Crop protection majors: BASF, Valagro (Syngenta Biologicals), UPL and FMC.
• Seaweed and extract specialists: Acadian Plant Health, BioAtlantis and Hello Nature (Italpollina).
• Biological and specialty nutrition firms: Koppert, Tradecorp (Rovensa) and Omnia Nutriology.

Competitive Benchmarking: Biostimulants Market

Table 8: Competitive Benchmarking for the Biostimulants Market (qualitative documentation ratings), 2026

Company	Seaweed and Extracts	Microbials	Dealer Reach	Recency
Valagro (Syngenta Biologicals)	High	Medium	High	High
Acadian Plant Health	High	Low	Medium	Medium
FMC	Medium	Medium	High	High
BASF	Medium	Medium	High	Medium
Koppert	Low	High	Medium	Medium

Grades show the volume of dated 2025 and 2026 disclosure behind each column for each company, not a share of biostimulant sales.

Key Developments in the Biostimulants Market

• On 27 August 2026, Syngenta Group said biologicals sales continued to perform strongly across all regions in the first half.[1]
• On 18 August 2026, Revista Cultivar reported that the decree for Brazil's bioinputs law was expected within weeks.[5]
• On 29 July 2026, FMC reported second quarter revenue of USD 867 million and lower Plant Health sales.[2]
• On 26 June 2026, the Council of the EU confirmed the Chemicals Omnibus (VI) agreement covering microbial biostimulants, EBIC said.[8]
• On 30 March 2026, AgroSpectrum reported India's Fourth Amendment Order, 2026 adding new biostimulant entries.[3]
• On 11 September 2025, Global Agriculture reported that 146 biostimulants were fully approved in India.[6]
• On 5 June 2025, H.R. 3783, the Plant Biostimulant Act of 2025, was introduced in the US House.[7]
• On 19 May 2025, Acadian Plant Health launched the ASM seed treatment for abiotic stress.[4]

Key Players in the Biostimulants Market

Crop Protection Majors

• BASF
• Valagro (Syngenta Biologicals)
• UPL
• FMC

Seaweed and Extract Specialists

• Acadian Plant Health
• BioAtlantis
• Hello Nature (Italpollina)

Biological and Specialty Nutrition Firms

• Koppert
• Tradecorp (Rovensa)
• Omnia Nutriology

Biostimulants Market - Report Scope

Table 9: Report Scope for the Biostimulants Market (coverage fields and definitions), 2026 to 2036

Coverage field	Report scope
Market breakdown	Active ingredient; crop type; application; region
Quantitative units	USD billion
Market definition	Extract-based, acid-based and other substances or micro-organisms applied to seeds, foliage or soil to support natural plant processes, stress tolerance and nutrient use, independent of nutrient content.
Regions covered	North America; Latin America; Western Europe; Eastern Europe; East Asia; South Asia and Pacific; Middle East and Africa
Countries covered	United States; Canada; Brazil; Mexico; Argentina; Chile; Germany; France; United Kingdom; Italy; Spain; Benelux; Nordics; Poland; Czech Republic; Romania; Hungary; China; Japan; South Korea; India; ASEAN; Australia and New Zealand; GCC Countries; South Africa; Türkiye; Israel
Key companies profiled	BASF, Valagro (Syngenta Biologicals), UPL, Koppert, Acadian Plant Health, FMC, BioAtlantis, Hello Nature (Italpollina), Tradecorp (Rovensa), Omnia Nutriology
Forecast period	2026 to 2036

Biostimulants Market - Research Methodology

Table 10: Research Methodology for the Biostimulants Market (research methods and approach), 2026 edition

Method	Approach
Data Sources	Crop input company results and launches, national registration notices, legislative texts, industry association releases and agricultural trade press from May 2025 onward.
Desk Research	Desk research covers registration rules, crop calendars, application formats, ingredient supply and grower margins.
Market Sizing and Forecasting	Sizing starts from the 2026 base of USD 4.5 billion and the 10.5% CAGR for 2026 to 2036.
Data Validation	Registration counts, sales figures and trial results were checked against the release, bill text or article that first carried them.

Biostimulants Market by Segments

Biostimulants Market segmented by Active Ingredient:

• Extract-based
• Acid-based
• Others

Biostimulants Market segmented by Crop Type:

• Row Crops
• Fruits and Vegetables
• Turfs and Ornamentals
• Other Crop Types

Biostimulants Market segmented by Application:

• Foliar
• Soil/Drip
• Seed/Coating

Biostimulants Market by Region

• North America
  • United States
  • Canada
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Chile
• Western Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Benelux
  • Nordics
• Eastern Europe
  • Poland
  • Czech Republic
  • Romania
  • Hungary
• East Asia
  • China
  • Japan
  • South Korea
• South Asia and Pacific
  • India
  • ASEAN
  • Australia and New Zealand
• Middle East and Africa
  • GCC Countries
  • South Africa
  • Türkiye
  • Israel

Research Sources and Bibliography

• [1] Syngenta Group. (2026, August 27). Syngenta Group strengthens profitability in H1 2026; EBITDA margins expand across all business units. https://www.syngentagroup.com/sites/default/files/2026-08/260827-Syngenta-Group-Q2-H1_EN_2949a0aa.pdf
• [2] FMC Corporation. (2026, July 29). FMC Corporation reports second quarter 2026 results (Form 8-K, Exhibit 99.1). https://www.sec.gov/Archives/edgar/data/0000037785/000003778526000139/fmcex991063026.htm
• [3] AgroSpectrum India. (2026, March 30). India expands biostimulant framework with sweeping Fertilizer Control Order Amendment. https://agrospectrumindia.com/news/43/33696/india-expands-biostimulant-framework-with-sweeping-fertilizer-control-order-amendment.html
• [4] Global Agriculture. (2025, May 19). Acadian launches advanced biostimulant seed treatment for abiotic stress management. https://www.global-agriculture.com/biologicals/acadian-launches-advanced-biostimulant-seed-treatment-for-abiotic-stress-management/
• [5] Revista Cultivar. (2026, August 18). Decreto da Lei de Bioinsumos deve avançar nas próximas semanas. https://www.revistacultivar.com.br/noticias/decreto-da-lei-de-bioinsumos-deve-avancar-nas-proximas-semanas
• [6] Global Agriculture. (2025, September 11). India ends provisional registration of biostimulants; only 146 products now approved under FCO, 9,352 products cancelled. https://www.global-agriculture.com/india-region/india-ends-provisional-registration-of-biostimulants-only-146-products-now-approved-under-fco-9352-products-cancelled/
• [7] U.S. Congress. (2025, June 5). H.R. 3783, Plant Biostimulant Act of 2025 (Introduced in House). https://www.govinfo.gov/content/pkg/BILLS-119hr3783ih/html/BILLS-119hr3783ih.htm
• [8] European Biostimulants Industry Council. (2026, July). Chemicals Omnibus (VI) agreement delivers on EBIC's requests for microbials and REACH. https://biostimulants.eu/news/chemicals-omnibus-vi-agreement-delivers-on-ebics-requests-for-microbials-and-reach/

This bibliography is provided for reader reference. The full report contains the complete reference list and detailed citations.

This Report Answers

• How big is the biostimulants market during 2026?
• What market size is projected by 2036?
• Which active ingredient holds notable share?
• Which crop type holds notable share?
• Which countries have notable growth?
• Which companies are notable in the market?